Back

Proteo-transcriptomic profiling of nasal mononuclear phagocytic system cells in human controlled allergen challenge

Voskamp, A. L.; Gerdes, M. L.; Menafra, R.; Duijster, E.; Kielbasa, S. M.; Groot Kormelink, T.; Tak, T.; Stam, K. A.; de Jong, N. W.; Hendricks, R. W.; Kloet, S. L.; Yazdanbakhsh, M.; De Jong, E. C.; Gerth van Wijk, R.; Smits, H. H.

2020-09-10 allergy and immunology
10.1101/2020.09.09.20189886
Show abstract

Innate mononuclear phagocytic system (MPS) cells preserve mucosal immune homeostasis. Here, we investigated their role at nasal mucosa following challenge with house dust mite. We combined single cell proteome and transcriptome profiling on immune cells from nasal biopsy cells of allergic rhinitis and non-allergic subjects, before and after repeated nasal allergen challenge. Nasal biopsies of patients showed infiltrating inflammatory HLA-DRhi CD14+ monocytes and CD16+ monocytes, and transcriptional changes in resident CD1C+ CD1A+ conventional dendritic cells (cDC)2 following challenge. Importantly, although clinically silent, non-allergic individuals displayed a distinct innate MPS response to allergen challenge: predominant infiltration of myeloid-derived suppressor cells (HLA-DRlow CD14+ monocytes), as well as cDC2 clusters expressing increased inhibitory/tolerogenic transcripts. Therefore, we identified not only clusters involved in airway inflammation but also a non-inflammatory, homeostatic blueprint of innate MPS responses to allergens in non-allergic individuals. Future therapies should target innate MPS for treatment of inflammatory airway diseases. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/20189886v2_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@e6e970org.highwire.dtl.DTLVardef@1e7e8bdorg.highwire.dtl.DTLVardef@60d55forg.highwire.dtl.DTLVardef@1587d4d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Allergy
based on 13 papers
Top 0.1%
11.1%
2
Nature Communications
based on 483 papers
Top 8%
10.1%
3
Nature Immunology
based on 14 papers
Top 0.1%
7.5%
4
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
7.5%
5
The Journal of Immunology
based on 19 papers
Top 0.1%
6.3%
6
Science Immunology
based on 15 papers
Top 0.1%
5.0%
7
Frontiers in Immunology
based on 140 papers
Top 2%
4.7%
50% of probability mass above
8
Clinical Immunology
based on 12 papers
Top 0.2%
4.5%
9
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 0.3%
3.8%
10
Immunity
based on 11 papers
Top 0.2%
2.9%
11
Cell Reports Medicine
based on 49 papers
Top 1%
2.8%
12
Cell Genomics
based on 34 papers
Top 0.8%
2.8%
13
JCI Insight
based on 63 papers
Top 2%
2.8%
14
Journal of Clinical Investigation
based on 50 papers
Top 1%
2.4%
15
eLife
based on 262 papers
Top 18%
1.6%
16
Cell
based on 28 papers
Top 1%
1.6%
17
European Respiratory Journal
based on 44 papers
Top 3%
1.6%
18
Cell Reports
based on 25 papers
Top 1%
1.2%
19
Nature Medicine
based on 88 papers
Top 13%
1.2%
20
Cells
based on 14 papers
Top 2%
0.8%
21
Communications Biology
based on 36 papers
Top 5%
0.8%
22
Journal of Clinical Immunology
based on 11 papers
Top 0.7%
0.8%
23
Journal for ImmunoTherapy of Cancer
based on 14 papers
Top 3%
0.8%
24
Science Translational Medicine
based on 40 papers
Top 5%
0.8%
25
Annals of the Rheumatic Diseases
based on 23 papers
Top 1%
0.7%
26
Clinical & Translational Immunology
based on 14 papers
Top 1%
0.7%